# Sze Huey Tan

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/sze-huey-tan/

## Facts

| Field | Value |
| --- | --- |
| Citations | 5,665 |
| Field | Head and Neck Cancer Studies |
| h-index | 36 |
| i10-index | 64 |
| Last Known Institution | Duke-NUS Medical School |
| OpenAlex ID | https://openalex.org/A5024789285 |
| ORCID iD | 0000-0002-3089-7379 |
| Works | 229 |

## Researcher papers

- [Sample Size Tables for Clinical Studies](https://scholariq.org/papers/sample-size-tables-for-clinical-studies/)
- [Intrinsic Subtypes of Gastric Cancer, Based on Gene Expression Pattern, Predict Survival and Respond Differently to Chemotherapy](https://scholariq.org/papers/intrinsic-subtypes-of-gastric-cancer-based-on-gene-expression-pattern-predict/)
- [Efficacy and Safety of Locoregional Radiotherapy With Chemotherapy vs Chemotherapy Alone in De Novo Metastatic Nasopharyngeal Carcinoma](https://scholariq.org/papers/efficacy-and-safety-of-locoregional-radiotherapy-with-chemotherapy-vs/)
- [Adoptive T-cell Transfer and Chemotherapy in the First-line Treatment of Metastatic and/or Locally Recurrent Nasopharyngeal Carcinoma](https://scholariq.org/papers/adoptive-t-cell-transfer-and-chemotherapy-in-the-first-line-treatment-of/)
- [Concurrent Chemo-Radiation With or Without Induction Gemcitabine, Carboplatin, and Paclitaxel: A Randomized, Phase 2/3 Trial in Locally Advanced Nasopharyngeal Carcinoma](https://scholariq.org/papers/concurrent-chemo-radiation-with-or-without-induction-gemcitabine-carboplatin-and/)
- [Sample Sizes for Clinical, Laboratory and Epidemiology Studies](https://scholariq.org/papers/sample-sizes-for-clinical-laboratory-and-epidemiology-studies/)
- [Induction Chemotherapy plus Concurrent Chemoradiotherapy in Endemic Nasopharyngeal Carcinoma: Individual Patient Data Pooled Analysis of Four Randomized Trials](https://scholariq.org/papers/induction-chemotherapy-plus-concurrent-chemoradiotherapy-in-endemic/)
- [Simultaneous Inhibition of PI3Kδ and PI3Kα Induces ABC-DLBCL Regression by Blocking BCR-Dependent and -Independent Activation of NF-κB and AKT](https://scholariq.org/papers/simultaneous-inhibition-of-pi3k-and-pi3k-induces-abc-dlbcl-regression-by/)
- [Radioembolisation with Y90-resin microspheres followed by nivolumab for advanced hepatocellular carcinoma (CA 209-678): a single arm, single centre, phase 2 trial](https://scholariq.org/papers/radioembolisation-with-y90-resin-microspheres-followed-by-nivolumab-for-advanced/)
- [The Correct Interpretation of Confidence Intervals](https://scholariq.org/papers/the-correct-interpretation-of-confidence-intervals/)
- [EP12.01-31 Updated First-line Osimertinib in Asian patients with Advanced EGFR-mutated Lung Cancer](https://scholariq.org/papers/ep12-01-31-updated-first-line-osimertinib-in-asian-patients-with-advanced-egfr/)

## Researcher topics

- [Head and Neck Cancer Studies](https://scholariq.org/topics/head-and-neck-cancer-studies/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Statistical Methods in Clinical Trials](https://scholariq.org/topics/statistical-methods-in-clinical-trials/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)

## Researcher university

- [Duke-NUS Medical School](https://scholariq.org/institutions/duke-nus-medical-school/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.